European clinicians will have a new weapon to combat cervical cancer with the introduction of Abbott Molecular's real-time polymerase chain reaction (PCR) based diagnostic test for human papillomavirus (HPV). The CE-marked assay can identify patients infected with specific viral genotypes known to pose the highest risk for progression to cervical cancer.

Victory Pharma, Inc, a privately held specialty pharmaceutical company, announced the launch of two additional dosage strengths of Naprelan (naproxen sodium) Controlled-Release Tablets. Naprelan is a once-daily, controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of a number of conditions, including osteoarthritis, rheumatoid arthritis and management of mild to moderate pain. Victory's promotional efforts will be directed primarily at pain management specialists, rheumatologists, orthopaedic surgeons and selected primary care physicians.

Bayer Diabetes Care introduced A1CNow+, it's innovative, portable, hand-held, meter-based, monitoring system for in-office measurement of A1C (HbA1c) or glycated haemoglobin - an important indicator of long-term blood sugar control.

According to the new research report, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical market grew by nearly 21% to register revenues in excess of US$ 2 Billion. The market is characterized by an increasing proportion of imported and high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine increased by nearly 20%, strongly pushing the value of pharmaceutical sales, despite a relatively ordinary growth in sales volume.